Mirum Pharmaceuticals Inc (NASDAQ:MIRM)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MIRM

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MIRM

  • Market Cap$458.710m
  • SymbolNASDAQ:MIRM
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS6047491013

Company Profile

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Latest MIRM news

Currently there for this company. Visit our news hub for other news .